Ira Weisberg’s Post

View profile for Ira Weisberg, graphic

President, SofPulse, Inc.

Sports injuries are common, and the subsequent pain is a normal physiological accompaniment to such an injury. The experience of pain is shaped by neurophysiological, cognitive, affective, social, and environmental influences. Given these complexities and, often, the absence of clear clinical guidelines, pain management strategies for both the professional athlete and the “weekend warriors” vary and often do not reflect an understanding of the cause and type of pain experienced by athletes. Nonsteroidal anti-inflammatory drugs (NSAIDs) are the most frequently used pain medication. NSAID use rates are concerning for several reasons, including concurrent use of multiple NSAIDs, multiple routes of administration, higher than the manufacturer's recommended dosing, use for prevention of pain, limited evidence-based clinical guidance, adverse effects, and limited evidence regarding effects on injury healing. Existing empirical research does not provide a sufficient body of evidence to guide athletes and healthcare professionals in making analgesic medication treatment decisions. SofPulse will provide pain relief without narcotics or any drugs. Additionally, using SofPulse will address the underlying cause of sports-related injuries - inflammation and edema. SofPulse is the only FDA-approved, technology-based, and patented pain relief product with a demonstrable ability to get you back to your life faster, with an improved quality-of-life benefit. SofPulse PEMF therapy treatment has been used in more than 20 thousand cases to manage acute pain and edema in both outpatient and home settings, offering patients a safe and effective pain management alternative. Contact us for more information. #painrelief #sofpulse #surgery #plasticsurgery #sportsinjuries #athletes #effectivepainrelief #painmanagement #edema #reducepain #veterans #veteranshealth #militarymedicine www.sofpulse.com

SofPulse

SofPulse

sofpulse.com

To view or add a comment, sign in

Explore topics